Literature DB >> 28653936

Repeated treatment with reserpine as a progressive animal model of depression.

Huma Ikram1, Darakhshan J Haleem2.   

Abstract

Treatment-resistant depression is a major health problem worldwide. Restricted validity of the existing animal models of depression along with the need for the study of progressive development of resistance to antidepressants, demands the modeling of a progressive animal model of depression. Present study was designed to test the hypothesis that the repeated administration of reserpine could serve as a progressive animal model of depression. Animals were injected with reserpine (1.0mg/kg; once a day) for three weeks. Results from the present study showed impaired locomotive effects of reserpine in Skinner's box following second as well as third week. These hypolocomotive effects were more pronounced after third week than the second week. Reserpine-induced behavioral depression was evident in the animals after 2 weeks, as assessed by using forced swim test. Depletion of 5-HT, dopamine and metabolites was also observed in the brain samples. Results from the present study suggest that repeated administration of reserpine could be serve as a progressive model of depression and could be used as a convenient and economic animal model for the face validity of anxiolytic compounds. Findings have potential implications with reference to the understanding and the management of treatment-resistant depression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28653936

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  7 in total

1.  Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression.

Authors:  Haitham S Mohammed; Yasser A Khadrawy
Journal:  Lasers Med Sci       Date:  2021-09-06       Impact factor: 3.161

2.  mGluR5 Facilitates Long-Term Synaptic Depression in a Stress-Induced Depressive Mouse Model.

Authors:  Xiangzhi Jiang; Wei Lin; Yuanyuan Cheng; Dongming Wang
Journal:  Can J Psychiatry       Date:  2019-09-16       Impact factor: 4.356

3.  Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1.

Authors:  Yan Chen; Jiongshan Zhang; Mengting Liu; Zengcheng Zou; Fenglin Wang; Hao Hu; Baoguo Sun; Shijun Zhang
Journal:  Biomed Res Int       Date:  2019-07-29       Impact factor: 3.411

Review 4.  Selecting an Appropriate Animal Model of Depression.

Authors:  Yuanzhen Hao; Huixiang Ge; Mengyun Sun; Yun Gao
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923

5.  Reserpine-induced altered neuro-behavioral, biochemical and histopathological assessments prevent by enhanced antioxidant defence system of thymoquinone in mice.

Authors:  Noreen Samad; Natasha Manzoor; Zahra Muneer; Sheraz A Bhatti; Imran Imran
Journal:  Metab Brain Dis       Date:  2021-07-26       Impact factor: 3.584

6.  Antidepressant and Anxiolytic-Like Effects of the Stem Bark Extract of Fraxinus rhynchophylla Hance and Its Components in a Mouse Model of Depressive-Like Disorder Induced by Reserpine Administration.

Authors:  Yu Ri Kim; Bo-Kyung Park; Chang-Seob Seo; No Soo Kim; Mi Young Lee
Journal:  Front Behav Neurosci       Date:  2021-06-17       Impact factor: 3.558

Review 7.  Therapeutic Potential of Hericium erinaceus for Depressive Disorder.

Authors:  Pit Shan Chong; Man-Lung Fung; Kah Hui Wong; Lee Wei Lim
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.